Literature DB >> 26182902

Do Orally Administered Immunoglobulin-Based Agents Represent the Future of IBD Therapeutics?

Jason M Shapiro1,2, Basavaraj Kerur3,4.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26182902     DOI： 10.1007/s10620-015-3802-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  Exclusive enteral nutrition in children with Crohn's disease.

Authors:  Andrew S Day; Robert N Lopez
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children.

Authors:  R B Heuschkel; C C Menache; J T Megerian; A E Baird
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-07       Impact factor: 2.839

3.  Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS.

Authors:  P D Greenberg; J P Cello
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-12-01

Review 4.  Inflammatory bowel disease.

Authors:  Clara Abraham; Judy H Cho
Journal:  N Engl J Med       Date:  2009-11-19       Impact factor: 91.245

5.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.

Authors:  Arlette Darfeuille-Michaud; Jérôme Boudeau; Philippe Bulois; Christel Neut; Anne-Lise Glasser; Nicolas Barnich; Marie-Agnès Bringer; Alexander Swidsinski; Laurent Beaugerie; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

6.  15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine.

Authors:  N Roos; S Mahé; R Benamouzig; H Sick; J Rautureau; D Tomé
Journal:  J Nutr       Date:  1995-05       Impact factor: 4.798

Review 7.  Bovine immunoglobulin protein isolates for the nutritional management of enteropathy.

Authors:  Bryon W Petschow; Anthony T Blikslager; Eric M Weaver; Joy M Campbell; Javier Polo; Audrey L Shaw; Bruce P Burnett; Gerald L Klein; J Marc Rhoads
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

8.  AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease.

Authors:  Kailash C Bhol; Daniel E Tracey; Brenda R Lemos; Gregory D Lyng; Emma C Erlich; David M Keane; Michael S Quesenberry; Amy D Holdorf; Lisa D Schlehuber; Shawn A Clark; Barbara S Fox
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

9.  Bovine immunoglobulin/protein isolate binds pro-inflammatory bacterial compounds and prevents immune activation in an intestinal co-culture model.

Authors:  Christopher J Detzel; Alan Horgan; Abigail L Henderson; Bryon W Petschow; Christopher D Warner; Kenneth J Maas; Eric M Weaver
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

10.  Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model.

Authors:  Abigail L Henderson; Meghan Wymore Brand; Ross J Darling; Kenneth J Maas; Christopher J Detzel; Jesse Hostetter; Michael J Wannemuehler; Eric M Weaver
Journal:  Dig Dis Sci       Date:  2015-05-31       Impact factor: 3.199
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.